National Clinical Impact Awards

RSTMH no longer able to support the National Clinical Impact Awards

The Advisory Committee on Clinical Impact Awards (ACCIA) has given notice that there will be further changes to the process for National Clinical Impact Awards for 2023. Further details are available here: Update on 2022 and 2023 awards rounds and changes to the role of membership organisations - GOV.UK

The RSTMH as a National Nominating Organisation (NNO) in recent years has supported eligible members who were applying for national awards with a ranked list and citation, after consideration of all applications by our ACCIA sub-Committee.

ACCIA have now decided that NNOs will no longer be able to submit rankings or citations for their members – furthermore NNOs now become Member Organisations (MOs).  This means that there will no longer be an opportunity to seek support via ranking and citation from the RSTMH or from any other MO.  MOs are not permitted to review, edit, or critique individual applications for national clinical impact awards. MOs are instead being encouraged to signpost their members to ACCIA training and tools as they are developed, to assist with members’ applications. All applications should therefore now be submitted directly to ACCIA.

We are very grateful to all the RSTMH ACCEA/ACCIA sub-committee members over many years, who have supported applicants for national awards with rankings and citations.

We understand from the ACCIA committee that the communication of the results of the 2022 award round has been delayed and there is currently no date for when applicants will be notified of the outcome.